Reveromycin B (CAS 144860-68-4)

Reveromycin B, with the CAS number 144860-68-4, is a member of the reveromycin class of compounds, which are isolated from the fermentation broth of various Streptomyces species. This compound is characterized by a spiroacetal enol ether structure, which is essential for its biological activity. The primary mechanism of action of Reveromycin B involves the inhibition of isoleucyl-tRNA synthetase, an enzyme critical for protein synthesis. By specifically targeting this enzyme, Reveromycin B disrupts the incorporation of the amino acid isoleucine into proteins, which impedes protein production and affects cell growth and proliferation. This specific inhibition makes it a useful tool for researchers studying the role of aminoacyl-tRNA synthetases in protein synthesis and cellular metabolism. In research environments, Reveromycin B has been employed to probe the effects of inhibited protein synthesis on cellular processes, particularly in the context of cell cycle regulation and apoptosis. Studies using this compound help explain the complex balance of protein synthesis and its impact on cell behavior, providing insights into the fundamental mechanisms that govern cellular growth and death. Through these investigations, Reveromycin B contributes to a deeper understanding of molecular biology and biochemistry, especially in deciphering how cells manage protein synthesis under various physiological and pathological conditions.